Kenya and South Korea Collaborate to Boost Local Vaccine Manufacturing
Kenya and South Korea Collaborate to Boost Local Vaccine Manufacturing

Kenya and South Korea Collaborate to Boost Local Vaccine Manufacturing

MoH News / Thu, 09/12/2024 - 11:19

ππšπ’π«π¨π›π’, π’πžπ©π­πžπ¦π›πžπ« 𝟏𝟏, πŸπŸŽπŸπŸ’ - Principal Secretary for Medical Services, Mr. Harry Kimtai,Β Β hosted a delegation from SK Bioscience of South Korea, led by Dr. Mike Ahn, Vice President of Global Operations.Β 

The meeting, held in Nairobi, focused on advancing ongoing discussions aimed at building capacity for local manufacturing of human vaccines in Kenya, with plans to extend these capabilities to the East African Community (EAC) and the wider African region.Β 

During the discussions, both parties reviewed the progress made in Kenya's vaccine manufacturing readiness, particularly in terms of facility development and workforce capacity. Mr. Kimtai highlighted efforts at state agencies, including the Kenya BioVax Institute, the Pharmacy and Poisons Board, and the Kenya Medical Research Institute (KEMRI), as critical components in achieving the country’s vaccine production goals.Β 

Also in attendance was Dr. Michael Lusiola, CEO of the Kenya BioVax Institute, who provided updates on facility readiness and workforce development efforts. The partnership with SK Bioscience is part of Kenya's broader strategy to enhance its public health infrastructure and ensure self-sufficiency in vaccine production.